Kim, H.H.; Lee, J.C.; Oh, I.-J.; Kim, E.Y.; Yoon, S.H.; Lee, S.Y.; Lee, M.K.; Lee, J.E.; Park, C.K.; Lee, K.Y.;
et al. Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer. Cancers 2024, 16, 528.
https://doi.org/10.3390/cancers16030528
AMA Style
Kim HH, Lee JC, Oh I-J, Kim EY, Yoon SH, Lee SY, Lee MK, Lee JE, Park CK, Lee KY,
et al. Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer. Cancers. 2024; 16(3):528.
https://doi.org/10.3390/cancers16030528
Chicago/Turabian Style
Kim, Hyeon Hwa, Jae Cheol Lee, In-Jae Oh, Eun Young Kim, Seong Hoon Yoon, Shin Yup Lee, Min Ki Lee, Jeong Eun Lee, Chan Kwon Park, Kye Young Lee,
and et al. 2024. "Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer" Cancers 16, no. 3: 528.
https://doi.org/10.3390/cancers16030528
APA Style
Kim, H. H., Lee, J. C., Oh, I.-J., Kim, E. Y., Yoon, S. H., Lee, S. Y., Lee, M. K., Lee, J. E., Park, C. K., Lee, K. Y., Lee, S. Y., Kim, S. J., Lim, J. H., & Choi, C.-m.
(2024). Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer. Cancers, 16(3), 528.
https://doi.org/10.3390/cancers16030528